Evidence map›Paper›PMID 39428534›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Possible Case of Elderly-onset Intestinal Behçet's Disease with Trisomy 8 Following COVID-19 Vaccination Exacerbated by COVID-19 Infection.

Toshitaka Yukishima, Shin-Ichiro Ohmura, Haruka Yonezawa, Akito Ueyama, Sumito Sato, Motoyuki Katayama, Seigo Ohkuma, Yoshiro Otsuki, Noriyoshi Ogawa

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Toshitaka YukishimaDepartment of Rheumatology, Seirei Hamamatsu General Hospital, Japan.
Shin-Ichiro OhmuraDepartment of Rheumatology, Seirei Hamamatsu General Hospital, Japan.
Haruka YonezawaDepartment of Rheumatology, Seirei Hamamatsu General Hospital, Japan.
Akito UeyamaDepartment of Surgery, Seirei Hamamatsu General Hospital, Japan.
Sumito SatoDepartment of Surgery, Seirei Hamamatsu General Hospital, Japan.
Motoyuki KatayamaDepartment of Radiology, Seirei Hamamatsu General Hospital, Japan.
Seigo OhkumaDepartment of Radiology, Seirei Hamamatsu General Hospital, Japan.
Yoshiro OtsukiDepartment of Pathology, Seirei Hamamatsu General Hospital, Japan.
Noriyoshi OgawaDivision of Immunology and Rheumatology, Third Department of Internal Medicine, Hamamatsu University School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) vaccines are effective in reducing the prevalence of this disease. However, some patients develop autoimmune diseases after vaccination. We herein report a case of elderly onset intestinal Behçet's disease (BD) with trisomy 8 following COVID-19 vaccination in which the disease was exacerbated by COVID-19 infection. The patient developed refractory stomatitis and genital ulcers two weeks after receiving the second vaccination and presented with bloody stool two years later. Intestinal BD with trisomy 8, exacerbated by COVID-19, was treated with high-dose glucocorticoids and infliximab; however, surgical intervention was required. The findings of this case suggest that the COVID-19 vaccination may induce BD.

Indexed as

Behcet SyndromeChromosomes, Human, Pair 8COVID-19COVID-19 VaccinesTrisomyAgedGlucocorticoidsHumansInfliximabIntestinal DiseasesSARS-CoV-2VaccinationCOVID-19 VaccinesGlucocorticoidsInfliximabBehçet's diseasecoronavirus diseasetrisomy 8vaccines

Identifiers

PMID39428534
PMCPMC11781933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.